Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with atrial fibrillation (an irregular heartbeat), confirmed by a heart tracing test (ECG), either in a clinic or through a wearable heart monitor.
Who may not be able to join:
- People who have had a stroke caused by a blood clot within the last 3 months before joining the trial.
- People with a low platelet count (a type of blood cell) or certain blood or bone marrow conditions, such as blood clotting disorders or conditions that affect how the blood flows (confirm with trial site).
- People who have an artificial (mechanical) heart valve.
- People who have a narrowing of the mitral heart valve caused by rheumatic disease.
- People who are already taking part in another study where the treatment being given is kept secret.
- People whose life expectancy is less than 3 years due to another serious illness, such as cancer or AIDS, based on their medical records.
- People who are pregnant.
- People who are unable to follow the treatment plan as required by the trial.
- People who do not agree to take part in the study.
- People who are currently in hospital or who have been discharged from hospital within the past month.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rungroj Krittayaphong, MD,FESC,FACC, Division of Cardiology, Department of Medicine, Siriraj Hospital, Mahidol university
Phone: 0815594286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of warfarin and NOACs use; Rate of ischemic stroke/TIA; Rate of systemic embolism; Rate of intracranial hemorrhage; Rate of major bleeding
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.